Nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) are a class of antiretroviral drugs that help manage HIV by blocking a key enzyme the virus needs to replicate its RNA into DNA. There ...
REDWOOD CITY, Calif., Dec. 15, 2021 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced the launch of its ...
With two catalytic activities and many substrates, how does HIV's reverse transcriptase enzyme know what to do to which substrate? Zooming in on the enzyme's molecular interactions provides ...